VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 52 filers reported holding VECTIVBIO HLDG AG in Q2 2023. The put-call ratio across all filers is 0.68 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $901,443 | – | 104,819 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,782,756 | $46,945,093 | 14.24% |
| TCG Crossover Management, LLC | 3,113,600 | $52,931,200 | 8.68% |
| Chicago Capital Management, LLC | 173,840 | $2,955,280 | 3.79% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 642,769 | $10,843,513 | 3.65% |
| Versor Investments LP | 1,210,379 | $20,419,094 | 3.54% |
| Crabel Capital Management, LLC | 460,405 | $7,767 | 3.20% |
| Kellner Capital, LLC | 145,597 | $2,475 | 2.84% |
| Vivo Capital, LLC | 2,333,300 | $39,362,771 | 2.72% |
| GLAZER CAPITAL, LLC | 1,875,178 | $31,878 | 2.11% |
| Orbimed Advisors | 5,156,561 | $87,661,537 | 1.59% |